Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 3662  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
E-IJD®-REVIEW ARTICLE
Year : 2022  |  Volume : 67  |  Issue : 4  |  Page : 479

A joint consensus of rheumatologists and dermatologists on early detection and effective management of psoriatic arthritis: India's perspective


1 From the Command Hospital, Kolkata, West Bengal, India
2 Nair Hospital, Mumbai, Maharashtra, India
3 Calcutta National Medical College, Kolkata, West Bengal, India
4 Global Hospital, Parel, Mumbai, Maharashtra, India
5 Base Hospital, Delhi, India
6 NIMS, Hyderabad, Telangana, India
7 Department of Rheumatology, Kilpauk Medical College, Chennai, Tamil Nadu, India
8 Department of Rheumatology, Command Hospital, Bangalore, Karnataka, India
9 Department of Rheumatology, Stanley Medical College, Chennai, Tamil Nadu, India
10 Department of Rheumatology and Clinical Immunology, Command Hospital (Eastern Command), Alipore Road, Kolkata, West Bengal, India
11 LHMC, Delhi, India
12 AFMC, Pune, Maharashtra, India
13 Sir Ganga Ram Hospital, Delhi, India

Correspondence Address:
Abhishek De
Calcutta National Medical College, Kolkata, West Bengal
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijd.ijd_939_20

Rights and Permissions

Psoriatic arthritis (PsA) is a chronic inflammatory disease with clinical manifestations, including inflammatory arthritis and the presence of psoriasis (PsO). The present consensus statement evaluated the early diagnosis and treatment approaches in the management of psoriasis and psoriatic arthritis by rheumatologists and dermatologists. For PAN India representation, a panel of eight rheumatologists and five dermatologists from different institutes in India were constituted. These thirteen experts were divided into two groups (rheumatologists group and dermatologist group) who received a set of questionnaires each for diagnosis and treatment approaches in the management of psoriasis and psoriatic arthritis. Based on the responses received, a panel discussion took place, where the experts identified the early diagnostic criteria for PsA considering: Clinical signs and symptoms, and questionnaire-based PsA screening, which includes Psoriasis Epidemiology Screening Tool (PEST) for dermatologists and Classification Criteria for Psoriatic Arthritis (CASPAR) for rheumatologists. The experts also recommended shift from conventional disease-modifying anti-rheumatic drugs (DMARDs) to biologics like secukinumab, when there is extensive skin involvement and TNF inhibitors when there is extensive joint involvement. Overall, the objective of the consensus was to assist rheumatologists and dermatologists in the early diagnosis and management of patients of PsA and PsO in their clinical practice.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed214    
    Printed4    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal